Zusammenfassung
Eine Schwangerschaft geht mit diversen physiologischen Veränderungen hormoneller Regelkreise einher. Akute Entgleisungen können sowohl die Mutter als auch das Kind vital gefährden. Neben Endokrinopathien, die im Rahmen der Schwangerschaft entstehen, stellen chronische endokrinologische Erkrankungen, wie z. B. Typ-1-Diabetes oder Morbus Basedow, in der Schwangerschaft eine besondere Herausforderung dar. Sowohl klinische Symptome, als auch die laborchemischen Referenzbereiche endokrinologischer Parameter werden durch die Schwangerschaft beeinflusst und können z. T. deutlich von denen außerhalb einer Schwangerschaft variieren. Zudem wird die Therapie durch eingeschränkte medikamentöse Optionen bei zugleich engeren Zielkorridoren erschwert. Diagnostik und therapeutisches Management erfordern daher insbesondere im Akutfall besondere Aufmerksamkeit. Diese Übersichtsarbeit fasst notfallrelevante endokrinologische Erkrankungen und Hintergrundinformationen zu Physiologie und Management zusammen.
Abstract
Endocrine emergencies during pregnancy can become life-threatening for both mother and fetus. In addition to some pregnancy-linked endocrine disorders, several pre-existing forms of endocrinopathy, such as Grave’s disease, type 1 diabetes and adrenal insufficiency might deteriorate acutely during pregnancy. Early diagnosis and management are challenging because the classical symptoms are often modified by pregnancy. Laboratory tests are subject to altered physiological ranges and pharmacological options are limited while therapeutic goals are stricter than in the non-pregnant patient. This article focuses on endocrine emergencies complicating pregnancy.
Literatur
Amin A, Robinson S, Teoh TG (2011) Endocrine problems in pregnancy. Postgrad Med J 87:116–124
Bakiri F, Bendib SE, Maoui R et al (1991) The sella turcica in Sheehan’s syndrome: computerized tomographic study in 54 patients. J Endocrinol Invest 14:193–196
Bellamy L, Casas J, Hingorani A, Williams D (2009) Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 373:1773–1779
Björnsdottir S, Cnattingius S, Brandt L et al (2010) Addison’s disease in women is a risk factor for an adverse pregnancy outcome. J Clin Endocrinol Metab 95:5249–5257
Caturegli P, Newschaffer C, Olivi A et al (2005) Autoimmune hypophysitis. Endocr Rev 26:599–614
Clausen T, Mathiesen E, Hansen T et al (2008) High prevalence of type 2 diabetes and pre-diabetes in adult offspring of women with gestational diabetes mellitus or type 1 diabetes: the role of intrauterine hyperglycemia. Diabetes Care 31:340–346
De Bellis A, Kelestimur F, Sinisi AA et al (2008) Anti-hypothalamus and anti-pituitaryantibodies may contribute to perpetuate the hypopituitarism in patients with Sheehan’s syndrome. Eur J Endocrinol 158:147–152
Drews K, Seremak-Mrozikiewicz A (2011) The optimal treatment of thyroid gland function disturbances during pregnancy. Curr Pharm Biotechnol 12:774–780
Führer D (2011) Thyroid illness during pregnancy. Internist (Berl) 52:1158–1166
Harbeck B, Lehnert H, Mönig H (2009) Schilddrüsenentzündungen in Schwangerschaft und Stillzeit. J Gynäkol Endokrinol 7:224–230
Howorka K, Pumprla J, Gabriel M et al (2001) Normalization of pregnancy outcome in pregestational diabetes through functional insulin treatment and modular out-patient education adapted for pregnancy. Diabet Med 18:965–972
Jovanovic L, Knopp RH, Kim H et al (2005) Elevated pregnancy losses at high and low extremes of maternal glucose in early normal and diabetic pregnancy: evidence for a protective adaptation in diabetes. Diabetes Care 28:1113–1117
Kamalkannan D, Baskar V, Barton D, Abdu T (2003) Diabetic ketoacidosis in pregnancy. Postgrad Med 79:454–457
Kautzky-Willer A, Bancher-Todesca D (2005) Endocrine changes in diabetic pregnancy. In: Djelmis J, Desoye G, Ivanisevic M (eds) Diabetology of pregnancy. Front Diabetes. Karger, Basel 17:18–33
Kelestimur F (2003) Sheehan’s syndrome. Pituitary 6:181–188
Klose S, Lehnert H (2011) Diabetisches Koma und perioperative Diabetestherapie. In: Burchardi H, Larsen R, Marx G, Muhl E, Schölmerich J (Hrsg) Die Intensivmedizin, Springer, Berlin S 727–739
Kovacs CS, Kronenberg HM (1997) Maternal-fetal calcium and bone metabolism during pregnancy, puerperium, and lactation. Endocr Rev 18:832–872
Lata I, Sahu S (2011) Management of paroxysmal hypertension due to incidental pheochromocytoma in pregnancy. J Emerg Trauma Shock 4:415-417
Lenders J (2011) Review topic: endocrine disorders in pregnancy phaeochromocytoma and pregnancy: a deceptive connection. Eur J Endocrinol 166:143–150
Lewandowski K, Hincz P, Grzesiak M et al (2010) New onset Addison’s disease presenting as prolonged hyperemesis in early pregnancy. Ginekol Pol 81:537–540
Sato K (2008) Hypercalcemia during pregnancy, puerperium, and lactation: review and a case report of hypercalcemic crisis after delivery due to excessive production of PTH-related protein (PTHrP) without malignancy (Humoral Hypercalcemia of Pregnancy). Endocr J 55:959–966
Schnatz PF, Curry SL (2002) Primary hyperparathyroidism in pregnancy: evidence-based management. Obstet Gynecol Surv 57:365–376
Schneider S, Freerksen N, Röhrig S et al (2011) Gestational diabetes and preeclampsia – similar risk factor profiles? Early Hum Dev (Epub ahead of print)
Wright C, Rifas-Shiman S, Rich-Edwards J et al (2009) Intrauterine exposure to gestational diabetes, child adiposity, and blood pressure. Am J Hypertens 22:215–220
Interessenkonflikt
Die korrespondierende Autorin gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Harbeck, B., Schütt, M. & Sayk, F. Endokrine Notfälle in der Schwangerschaft. Med Klin Intensivmed Notfmed 107, 110–117 (2012). https://doi.org/10.1007/s00063-011-0035-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00063-011-0035-4